Expression of the cell surface mucin gene family in adenocarcinomas.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMID 15375564)

Published in Int J Oncol on October 01, 2004

Authors

Leisl M Packer1, Stephanie J Williams, Shirley Callaghan, David C Gotley, Michael A McGuckin

Author Affiliations

1: Epithelial Cancer and Mucosal Biology Laboratory, Mater Medical Research Institute, Mater Health Services, South Brisbane, Queenslands 4101, Australia.

Articles citing this

Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer (2009) 5.31

MUC1 limits Helicobacter pylori infection both by steric hindrance and by acting as a releasable decoy. PLoS Pathog (2009) 1.69

Intracellular MUC1 peptides inhibit cancer progression. Clin Cancer Res (2009) 1.23

The tumor microenvironment in colorectal carcinogenesis. Cancer Microenviron (2010) 1.23

Current status of mucins in the diagnosis and therapy of cancer. Biofactors (2009) 1.17

Mucin glycan foraging in the human gut microbiome. Front Genet (2015) 1.14

Changes in the mucosal barrier during acute and chronic Trichuris muris infection. Parasite Immunol (2011) 1.11

Mucin 13: structure, function, and potential roles in cancer pathogenesis. Mol Cancer Res (2011) 1.04

Mucin gene expression and mouse middle ear epithelium. Int J Pediatr Otorhinolaryngol (2010) 0.91

Increased expression and aberrant localization of mucin 13 in metastatic colon cancer. J Histochem Cytochem (2012) 0.87

Dose-dependent benefits of quercetin on tumorigenesis in the C3(1)/SV40Tag transgenic mouse model of breast cancer. Cancer Biol Ther (2014) 0.79

Functions and regulation of MUC13 mucin in colon cancer cells. J Gastroenterol (2013) 0.77

Influence of monoclonal anti-Lewis b, anti-H type 1, and anti-sialyl Lewis x antibodies on binding of Helicobacter pylori to MUC1 mucin. Mol Cell Biochem (2013) 0.75

Exploring the role and diversity of mucins in health and disease with special insight into non-communicable diseases. Glycoconj J (2015) 0.75

Articles by these authors

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol (2005) 5.40

Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis. PLoS Med (2008) 4.24

Structure and function of the polymeric mucins in airways mucus. Annu Rev Physiol (2008) 3.63

Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol (2010) 3.32

MUC1 cell surface mucin is a critical element of the mucosal barrier to infection. J Clin Invest (2007) 2.90

Comparison of the outcomes between open and minimally invasive esophagectomy. Ann Surg (2007) 2.60

CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res (2013) 2.57

Radiofrequency ablation of liver tumors: a systematic review. Arch Surg (2006) 2.22

Mucin dynamics in intestinal bacterial infection. PLoS One (2008) 1.88

Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial. JAMA (2013) 1.88

IgG antibodies against common gut bacteria are more diagnostic for Crohn's disease than IgG against mannan or flagellin. Am J Gastroenterol (2007) 1.71

MUC1 limits Helicobacter pylori infection both by steric hindrance and by acting as a releasable decoy. PLoS Pathog (2009) 1.69

Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial. Eur J Cancer (2011) 1.54

Genome-wide copy number analysis in esophageal adenocarcinoma using high-density single-nucleotide polymorphism arrays. Cancer Res (2008) 1.50

Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev (2005) 1.49

Expression of HOXB2, a retinoic acid signaling target in pancreatic cancer and pancreatic intraepithelial neoplasia. Clin Cancer Res (2005) 1.48

Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry. Clin Cancer Res (2010) 1.32

The interplay between endoplasmic reticulum stress and inflammation. Immunol Cell Biol (2012) 1.31

Factors associated with postoperative pulmonary morbidity after esophagectomy for cancer. Ann Surg Oncol (2010) 1.24

Campylobacter jejuni response to human mucin MUC2: modulation of colonization and pathogenicity determinants. J Med Microbiol (2008) 1.19

A novel microbiota stratification system predicts future exacerbations in bronchiectasis. Ann Am Thorac Soc (2014) 1.17

Spontaneous apoptosis of blood dendritic cells in patients with breast cancer. Breast Cancer Res (2005) 1.14

The MUC13 cell surface mucin is highly expressed by human colorectal carcinomas. Hum Pathol (2007) 1.14

Mucins in inflammatory bowel diseases and colorectal cancer. J Gastroenterol Hepatol (2012) 1.14

Expression of the CD44v2-10 isoform confers a metastatic phenotype: importance of the heparan sulfate attachment site CD44v3. Cancer Res (2003) 1.13

The MUC13 cell-surface mucin protects against intestinal inflammation by inhibiting epithelial cell apoptosis. Gut (2011) 1.13

Generation of ligand-receptor alliances by "SEA" module-mediated cleavage of membrane-associated mucin proteins. Protein Sci (2002) 1.10

β-glucan triggers spondylarthritis and Crohn's disease-like ileitis in SKG mice. Arthritis Rheum (2012) 1.10

Endothelial cell serine proteases expressed during vascular morphogenesis and angiogenesis. Thromb Haemost (2003) 1.08

Defining cure for esophageal cancer: analysis of actual 5-year survivors following esophagectomy. Ann Surg Oncol (2011) 1.05

Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype. Mod Pathol (2013) 1.04

A novel NOD1- and CagA-independent pathway of interleukin-8 induction mediated by the Helicobacter pylori type IV secretion system. Cell Microbiol (2012) 1.04

IL-10 promotes production of intestinal mucus by suppressing protein misfolding and endoplasmic reticulum stress in goblet cells. Gastroenterology (2012) 1.02

Risk stratification for early esophageal adenocarcinoma: analysis of lymphatic spread and prognostic factors. Ann Surg Oncol (2010) 1.00

Serine protease(s) secreted by the nematode Trichuris muris degrade the mucus barrier. PLoS Negl Trop Dis (2012) 0.99

Localized suppression of inflammation at sites of Helicobacter pylori colonization. Infect Immun (2011) 0.98

Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinoma. Mol Cancer (2008) 0.97

Improved in vitro model systems for gastrointestinal infection by choice of cell line, pH, microaerobic conditions, and optimization of culture conditions. Helicobacter (2007) 0.96

ZAP-70 genotype disrupts the relationship between microbiota and host, leading to spondyloarthritis and ileitis in SKG mice. Arthritis Rheumatol (2014) 0.96

Listeria monocytogenes internalins bind to the human intestinal mucin MUC2. Arch Microbiol (2008) 0.96

KCNN4 gene variant is associated with ileal Crohn's Disease in the Australian and New Zealand population. Am J Gastroenterol (2010) 0.95

Whole genome expression array profiling highlights differences in mucosal defense genes in Barrett's esophagus and esophageal adenocarcinoma. PLoS One (2011) 0.94

Interleukin-23 mediates the intestinal response to microbial β-1,3-glucan and the development of spondyloarthritis pathology in SKG mice. Arthritis Rheumatol (2014) 0.92

Expression of MUC1 splice variants in benign and malignant ovarian tumours. Int J Cancer (2002) 0.92

Glucocorticoids alleviate intestinal ER stress by enhancing protein folding and degradation of misfolded proteins. J Exp Med (2013) 0.88

Paclitaxel resistance and multicellular spheroid formation are induced by kallikrein-related peptidase 4 in serous ovarian cancer cells in an ascites mimicking microenvironment. PLoS One (2013) 0.88

Mucin 1 (MUC1) is a novel partner for MAL2 in breast carcinoma cells. BMC Cell Biol (2009) 0.86

Matrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasis. Ann Am Thorac Soc (2015) 0.86

Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response. Ann Surg Oncol (2008) 0.86

Extracellular cathepsin K exerts antimicrobial activity and is protective against chronic intestinal inflammation in mice. Gut (2012) 0.86

Thoracoscopic-assisted esophagectomy for esophageal cancer: analysis of patterns and prognostic factors for recurrence. Ann Surg (2010) 0.86

Gastrointestinal cell lines form polarized epithelia with an adherent mucus layer when cultured in semi-wet interfaces with mechanical stimulation. PLoS One (2013) 0.85

O-Linked glycome and proteome of high-molecular-mass proteins in human ovarian cancer ascites: Identification of sulfation, disialic acid and O-linked fucose. Glycobiology (2012) 0.84

Muc1 limits Helicobacter felis binding to gastric epithelial cells but does not limit colonization and gastric pathology following infection. Helicobacter (2008) 0.84

T cell transfer model of colitis: a great tool to assess the contribution of T cells in chronic intestinal inflammation. Methods Mol Biol (2012) 0.83

Techniques for assessment of interactions of mucins with microbes and parasites in vitro and in vivo. Methods Mol Biol (2012) 0.83

Endocrine impact of Helicobacter pylori: focus on ghrelin and ghrelin o-acyltransferase. World J Gastroenterol (2011) 0.82

Treatment results of curative gastric resection from a specialist Australian unit: low volume with satisfactory outcomes. Gastric Cancer (2013) 0.81

Feasibility of chemoradiation therapy with protracted infusion of 5-fluorouracil for esophageal cancer patients not suitable for cisplatin. Int J Clin Oncol (2005) 0.80

A novel mouse model of veno-occlusive disease provides strategies to prevent thioguanine-induced hepatic toxicity. Gut (2012) 0.79

Carbohydrate binding and gene expression by in vitro and in vivo propagated Campylobacter jejuni after immunomagnetic separation. J Basic Microbiol (2012) 0.79

Neutralizing IL-23 is superior to blocking IL-17 in suppressing intestinal inflammation in a spontaneous murine colitis model. Inflamm Bowel Dis (2015) 0.79

Tumor progression in hepatocellular carcinoma: relationship with tumor stroma and parenchymal disease. J Gastroenterol Hepatol (2003) 0.79

Detecting, visualising, and quantifying mucins. Methods Mol Biol (2012) 0.77

Symptoms, investigations and management of patients with cancer of the oesophagus and gastro-oesophageal junction in Australia. Med J Aust (2010) 0.76

Consideration of mesh-related complications. Ann R Coll Surg Engl (2008) 0.75

Lynch syndrome-associated breast cancers do not overexpress chromosome 11-encoded mucins. Mod Pathol (2013) 0.75

Long-term Health-related Quality of Life Following Esophagectomy: A Nonrandomized Comparison of Thoracoscopically Assisted and Open Surgery. Ann Surg (2017) 0.75